We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Biocomputing Advance Presages Logic Control over Biochemical Processes

By LabMedica International staff writers
Posted on 16 Jun 2011
Researchers from the California Institute of Technology (Caltech; Pasadena, CA, USA) have built the most complex biochemical circuit ever created.

Building these circuits allows researchers from Caltech to study the principles of computing with biologic systems, and to design biochemical pathways with decision-making capabilities. Such circuits would give biochemists unprecedented control in designing chemical reactions for applications in biological and chemical engineering. For example, a synthetic biochemical circuit could be introduced into a clinical blood sample to detect the levels of a variety of molecules in the sample, and integrate that information into a diagnosis of any possible pathology.

"We're trying to borrow the ideas that have had huge success in the electronic world, such as abstract representations of computing operations, programming languages, and compilers, and apply them to the biomolecular world," said Dr. Lulu Qian, a senior postdoctoral scholar in bioengineering at Caltech and lead author on a paper published in the June 3, 2011, issue of the journal Science.

Along with Dr. Erik Winfree, Caltech professor of computer science, computation, and neural systems, and bioengineering, Dr. Qian utilized a new type of DNA-based component to build the largest artificial biochemical circuit ever made. Earlier lab-made biochemical circuits were limited because they worked less reliably and predictably when scaled to larger sizes, Dr. Qian explained. The most probable reason behind this limitation is that such circuits require various molecular structures to implement different functions, making large systems more complicated and difficult to debug. The researchers' new application, however, involves components that are simple, standardized, effective, and scalable.

"You can imagine that in the computer industry, you want to make better and better computers," Dr. Qian said. "This is our effort to do the same. We want to make better and better biochemical circuits that can do more sophisticated tasks, driving molecular devices to act on their environment."

To construct their circuits, the researchers used pieces of DNA to make logic gates--devices that produce on-off output signals in response to on-off input signals. Biochemical circuits comprise molecules floating in salt water. DNA-based logic gates receive and produce molecules as signals. The molecular signals travel from one specific gate to another, connecting the circuit as if they were wires.

Dr. Winfree and his colleagues first built such a biochemical circuit in 2006. In this work, DNA signal molecules connected several DNA logic gates to each other, forming a multilayered circuit. However, this earlier circuit consisted of only 12 different DNA molecules, and the circuit slowed down by a few orders of magnitude when expanded from a single logic gate to a five-layered circuit. In their new design, the researchers have engineered logic gates that are simpler and more reliable, allowing them to make circuits at least five times larger.

The new logic gates are made from pieces of either short, single-stranded DNA or partially double-stranded DNA in which single strands stick out like tails from the DNA's double helix. The single-stranded DNA molecules act as input and output signals that interact with the partially double-stranded ones.

"The molecules are just floating around in solution, bumping into each other from time to time," Dr. Winfree explained. "Occasionally, an incoming strand with the right DNA sequence will zip itself up to one strand while simultaneously unzipping another, releasing it into solution and allowing it to react with yet another strand." Because the researchers can encode whatever DNA sequence they want, they have full control over this process. "You have this programmable interaction," he commented.

Drs. Qian and Winfree made several circuits with their approach, but the largest--containing 74 different DNA molecules--can compute the square root of any number up to 15 (essentially, a four-bit binary number) and round down the answer to the nearest integer. The researchers then monitor the concentrations of output molecules during the calculations to determine the answer. The calculation takes about 10 hours, so it will not replace a PC anytime soon. However, the purpose of these circuits is not to compete with electronics, but to give scientists logic control over biochemical processes.

All the logic gates have identical structures with different sequences. As a result, they can be standardized, so that the same types of components can be wired together to make different circuits. Moreover, according to Dr. Qian, the user does not have to know anything about the molecular machinery behind the circuit to make one. If you want a circuit that could automatically diagnoses a disease, one just submits an abstract representation of the logic functions in your design to a compiler that the researchers provide online, which will then translate the design into the DNA components needed to build the circuit.

The circuit components are also tunable. By adjusting the concentrations of the types of DNA, the researchers can alter the functions of the logic gates. The circuits are versatile, featuring plug-and-play components that can be easily reconfigured to rewire the circuit. The simplicity of the logic gates also allows for efficient techniques that synthesize them in parallel.

"Like Moore's Law for silicon electronics, which says that computers are growing exponentially smaller and more powerful every year, molecular systems developed with DNA nanotechnology have been doubling in size roughly every three years," Dr. Winfree says.

Dr. Qian added, "The dream is that synthetic biochemical circuits will one day achieve complexities comparable to life itself."

Related Links:

California Institute of Technology


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TORCH Infections Test
TORCH Panel
New
Multi-Function Pipetting Platform
apricot PP5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.